|
|
Article: Attendees Told European M&As Not Only Possible, But Necessary.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BioWorld International Correspondent
LONDON - Push is coming to shove.
There has been much talk in the past 18 months to two years of the need for the European biotechnology sector to build its strength through mergers and acquisitions. Now there is no choice but to consolidate because the money is running out, and so is investors' patience.
That was the stark message to CEOs at the 3rd annual BIA European CEO and Investor Conference in a session titled "Making the M&A Moves: the consolidation opportunity."
There is no shortage of rumors about imminent biotechnology mergers and acquisitions, but "the question is, is this all talk or ...